On the one hand, ginsenoside Rg3 inhibits lung cancer migration and invasion by down-regulating fucosyltransferase IV (FUT4)-mediated EGFR inactivation and blocking MAPK and NF-κB signaling pathways [15]. The gene discussed is EGFR; the disease is lung carcinoma.